Increased Options Activity Noted in KALV, AMED, TRUP Stocks

Options trading spikes for KALVista Pharmaceuticals, Amedisys, and Trupanion are raising eyebrows among investors. Increased volume may indicate potential stock price movements ahead.

Date: 20-02-2025

AI Rating: 6

Options Trading Activity

The reported increases in options trading volumes for KALVista Pharmaceuticals (KALV), Amedisys (AMED), and Trupanion (TRUP) indicate heightened investor interest and potential price movements influenced by these activities.

KALV's trading volume reached 5,088 contracts, surpassing its average daily volume by 159.1%. This unusual activity may point to investor speculation or expectations regarding price increases, especially with a particular focus on the $12.50 strike call option expiring in April 2025.

Similarly, AMED's options trading volume of 2,814 contracts represents 143.7% of its average daily trading volume, with significant attention on the $90 strike put option. Such activity could imply bearish sentiment among traders leading up to September 2025.

TRUP also saw substantial trading with 5,364 contracts traded, equating to 120.7% of its average volume, highlighting buy interest around the $40 strike call option expiring in February 2025. This could indicate optimism about the company's near-term prospects.

Overall, these spikes in options activity could lead to greater volatility in stock prices as traders position themselves based on future expectations, fundamentally increasing risks and opportunities for investors.

Stocks: KALV AMED TRUP